![Ho Sung Cho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ho Sung Cho
Directeur/Bestuurslid bij
California Biomedical Innovation Alliance
Profiel
Ho Sung Cho is currently the Director at BIOCOM and the Director at California Biomedical Innovation Alliance.
Previously, he worked as the Associate Director-Protein Chemistry at Xencor, Inc., Director at Viron Therapeutics, Inc., Director at Boundless Bio, Inc., Vice President-Biotherapeutics at Celgene Corp., Team Leader at Exelixis, Inc., Vice President-Technology & Process Development at Ambrx, Inc., Staff Scientist at Lawrence Berkeley National Laboratory, and Medicinal Chemist at Burroughs Wellcome.
He holds a doctorate degree from the University of California.
Actieve functies van Ho Sung Cho
| Bedrijven | Functie | Begin |
|---|---|---|
California Biomedical Innovation Alliance
 California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Directeur/Bestuurslid | 28-08-2017 |
Eerdere bekende functies van Ho Sung Cho
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01-11-2019 |
| BOUNDLESS BIO, INC. | Directeur/Bestuurslid | - |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Directeur/Bestuurslid | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Directeur/Bestuurslid | - |
Burroughs Wellcome | Corporate Officer/Principal | - |
Opleiding van Ho Sung Cho
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
65
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services Provides scientific and technological services | Commercial Services |
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Researches on environmental studies, nanoscience and quantitative biology, physics and nuclear energy | Commercial Services |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for inflammatory disorders | Health Technology |
Burroughs Wellcome | |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Biomedical Innovation Alliance
California Biomedical Innovation Alliance BiotechnologyHealth Technology Provides biomedical advocacy and community services | Health Technology |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
